EUVIMEDEUVIMED entdecken
Crossref

Clinical Outcomes After Scoring‐Balloon and Sirolimus‐Eluting Balloon Strategy in Diffuse Small‐Vessel Coronary Artery Disease (SCA‐DEB Study): A Single‐Center Prospective Study

Dobrin Vassilev, Niya Mileva iD, Panayot Panayotov, Vladimir Shurupov, Ilter Pazardzhakli, Gavril Stoev, Slawomir Golebiewski, Gianluca Rigatelli, Robert J Gil

Catheterization and Cardiovascular Interventions · 02.08.2026

DOI: 10.1002/ccd.70784 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Catheterization and Cardiovascular Interventions, online erschienen am 02.08.2026. Verfasst von Dobrin Vassilev und 8 weiteren Autor:innen. Beteiligte Einrichtung: Medica Cor Hospital, Ruse, Bulgaria. Hauptthemen laut MEDLINE: Sirolimus, Angioplasty, Balloon, Coronary, Coronary Artery Disease, Cardiovascular Agents. Die Arbeit nennt 17 Literaturangaben. Gefördert von: European Union-NextGenerationEU through the National Recovery and Resilience Plan of the Republic of Bulgaria.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The treatment of diffuse coronary artery disease is challenging, with high rates of repeat revascularization without satisfactory treatment.

Aims

We designed a prospective, single‐center, single‐arm study to evaluate the feasibility and safety of a new strategy for the treatment of diffuse, small‐vessel coronary artery disease using a systematic combination of Scoring‐balloon Angioplasty and Sirolimus‐eluting balloon Angioplasty.

Methods

We included patients with diffuse (lesion length ≥ 20 mm) and small vessel (diameter 1.5–2.75 mm) coronary disease. Patients with STEMI, left main stenosis, and a life expectancy of less than 24 months were excluded. The procedure strategy was scoring‐balloon angioplasty (SBA), 1:1 diameter ratio with distal reference plus sirolimus‐eluting balloon angioplasty (SEB) using Mozec balloon (Meril, India).

Results

From December 2022 until June 2025, 167 patients with 194 vessels were included. The mean age was 67 ± 9 years, 71% males, 92% with dyslipidemia, and 44% diabetics. The left anterior descending artery was the most frequently treated vessel (66%). The mean reference vessel diameter was 2.1 ± 0.74 mm, MLD 0.71 ± 0.31 mm, and %DS 67 ± 14%. The mean lesion length was 35 ± 15 mm. For a median clinical follow‐up of 15 [8−29] months, the overall rate of MACE was 5.4%, 4.8% patients had TLR, and the total percentage of POCE was 10.2%.

Conclusions

A novel strategy using a combination of scoring balloon angioplasty followed by sirolimus‐eluting balloon inflation for the treatment of diffuse coronary artery disease yields promising angiographic and clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SirolimusAngioplasty, Balloon, CoronaryCoronary Artery DiseaseCardiovascular AgentsCardiac CathetersCoated Materials, BiocompatibleHumansMaleProspective StudiesFemaleTreatment OutcomeAgedTime FactorsFeasibility StudiesCoronary AngiographyMiddle AgedSeverity of Illness Index

Stichwörter der Autor:innen

diffuse coronary artery diseasedrug‐coated balloonischemiasmall vessel disease

Substanzen

SirolimusCardiovascular AgentsCoated Materials, Biocompatible

Autor:innen und Institutionen

  • Medica Cor Hospital, Ruse, Bulgaria.
  • Ruse University "Angel Kanchev", Ruse, Bulgaria.
  • Medical University of Pleven, Pleven, Bulgaria.
  • Department of Interventional Cardiology and Internal Diseases, Military National Research Institute, Legionowo, Poland.
  • Department of Cardiology, Padova South Hospitals, Monselice, Italy.
  • National Medical Institute of Internal Affairs and Administration Ministry, Warsaw, Poland.

ORCID-Profile: Niya Mileva

Förderung

  • European Union-NextGenerationEU through the National Recovery and Resilience Plan of the Republic of Bulgaria

Zitieren

APA

Vassilev, D., Mileva, N., Panayotov, P., Shurupov, V., Pazardzhakli, I., Stoev, G., Golebiewski, S., Rigatelli, G., & Gil, R. J. (2026). Clinical Outcomes After Scoring‐Balloon and Sirolimus‐Eluting Balloon Strategy in Diffuse Small‐Vessel Coronary Artery Disease (SCA‐DEB Study): A Single‐Center Prospective Study. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70784

Vancouver

Vassilev D, Mileva N, Panayotov P, Shurupov V, Pazardzhakli I, Stoev G, et al. Clinical Outcomes After Scoring‐Balloon and Sirolimus‐Eluting Balloon Strategy in Diffuse Small‐Vessel Coronary Artery Disease (SCA‐DEB Study): A Single‐Center Prospective Study. Catheterization and Cardiovascular Interventions. 2026. doi:10.1002/ccd.70784

BibTeX
@article{Vassilev2026,
  author = {Vassilev, Dobrin and Mileva, Niya and Panayotov, Panayot and Shurupov, Vladimir and Pazardzhakli, Ilter and Stoev, Gavril and Golebiewski, Slawomir and Rigatelli, Gianluca and Gil, Robert J},
  title = {Clinical Outcomes After Scoring‐Balloon and Sirolimus‐Eluting Balloon Strategy in Diffuse Small‐Vessel Coronary Artery Disease (SCA‐DEB Study): A Single‐Center Prospective Study},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2026},
  doi = {10.1002/ccd.70784}
}
Kostenlos starten →